[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

Melatonin potentials against viral infections including COVID-19: Current evidence and new findings

KB Juybari, MH Pourhanifeh, A Hosseinzadeh… - Virus research, 2020 - Elsevier
Viral infections are dangerous diseases for human health worldwide, which lead to
significant morbidity and mortality each year. Because of their importance and the lack of …

The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and …

DB Kell, E Pretorius - Biochemical Journal, 2022 - portlandpress.com
Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …

[HTML][HTML] The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment

EJ van Vuren, SF Steyn, CB Brink, M Möller… - Biomedicine & …, 2021 - Elsevier
The recent outbreak of the corona virus disease (COVID-19) has had major global impact.
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …

Melatonin effects on sleep quality and outcomes of COVID‐19 patients: an open‐label, randomized, controlled trial

SA Mousavi, K Heydari, H Mehravaran… - Journal of Medical …, 2022 - Wiley Online Library
This trial aims to evaluate the effectiveness of adding melatonin to the treatment protocol of
hospitalized coronavirus disease 2019 (COVID‐19) patients. This was an open‐label …

[HTML][HTML] Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment

MT De Mello, A Silva, R de Carvalho Guerreiro… - Sleep …, 2020 - thieme-connect.com
The fear and uncertainty caused by the coronavirus disease 2019 (COVID-19) pandemic,
threats to survival are one of the main problems of everyday life; however, mental health …

[HTML][HTML] Elderly as a high-risk group during COVID-19 pandemic: effect of circadian misalignment, sleep dysregulation and melatonin administration

DP Cardinali, GM Brown, RJ Reiter… - Sleep and …, 2020 - Springer
The association of age with a higher vulnerability to COVID-19 infection is a subject of major
importance. Several factors, including higher stress due to social isolation, diminished …

Efficacy of melatonin in the treatment of patients with COVID‐19: a systematic review and meta‐analysis of randomized controlled trials

SH Lan, HZ Lee, CM Chao, SP Chang… - Journal of medical …, 2022 - Wiley Online Library
This study investigated the effect of melatonin on clinical outcomes in patients with
coronavirus disease 2019 (COVID‐19). We searched PubMed, the Web of Science, the …

The prophylaxis and treatment potential of supplements for COVID-19

A Sahebnasagh, F Saghafi, R Avan, A Khoshi… - European journal of …, 2020 - Elsevier
The global impact of the new coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), infection that caused COVID-19 has been evident in the last few months …

[HTML][HTML] Melatonin–Microbiome two-sided interaction in Dysbiosis-associated conditions

MI Iesanu, CDM Zahiu, IA Dogaru, DM Chitimus… - Antioxidants, 2022 - mdpi.com
Melatonin is a pineal indolamine, allegedly known as a circadian rhythm regulator, and an
antioxidative and immunomodulatory molecule. In both experimental and clinical trials …